Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIQ-AI Share News (IQAI)

  • There is currently no data for IQAI

IQ-AI News

TRADING UPDATES: Getech signs deal; AfriTin confirms name change
10 Jan 2023

TRADING UPDATES: Getech signs deal; AfriTin confirms name change

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

IN BRIEF: IQ-AI shares plummet on widening interim loss
16 Aug 2022

IN BRIEF: IQ-AI shares plummet on widening interim loss

IQ-AI Ltd - Jersey-based medical services firm - Posts larger interim pretax loss due to increased administrative costs. Pretax loss in the half-year ...

IN BRIEF: IQ-AI launches IB Clinic on Bayer Calantic platform
11 Jul 2022

IN BRIEF: IQ-AI launches IB Clinic on Bayer Calantic platform

IQ-AI Ltd - Jersey-based medical services firm - Says its medical imaging analysis software, IB Clinic, is now available via the newly launched Bayer ...

IN BRIEF: IQ-AI shares rise with submission of application to US FDA
31 May 2022

IN BRIEF: IQ-AI shares rise with submission of application to US FDA

IQ-AI Ltd - Jersey-based medical services firm - Says subsidiary Imaging Biometrics LLC submits 510(k) application to US Food & Drug Administration fo...

SMALL-CAP WINNERS & LOSERS: IQ-AI's IB Zero G moves closer to approval
31 May 2022

SMALL-CAP WINNERS & LOSERS: IQ-AI's IB Zero G moves closer to approval

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Tuesday.

IQ-AI imaging technology gets vote of confidence in US study
3 May 2022

IQ-AI imaging technology gets vote of confidence in US study

(Alliance News) - IQ-AI Ltd unit Imaging Biometrics on Tuesday said a study concluded its imaging technology was successful in identifying tumours.

TRADING UPDATES: Impellam's first quarter beats pre-virus levels
28 Apr 2022

TRADING UPDATES: Impellam's first quarter beats pre-virus levels

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

IN BRIEF: IQ-AI opens oral gallium malotate trial for enrolment
9 Mar 2022

IN BRIEF: IQ-AI opens oral gallium malotate trial for enrolment

IQ-AI Ltd - Jersey-based medical services firm - Says phase one clinical trial for oral gallium maltolate is open for enrolment. Patient recruitment i...